Skip to main content

Alcoholic Hepatitis clinical trials at UC Health
1 research study open to new patients

  • Pegfilgrastim in Patients With Alcoholic Hepatitis

    open to eligible people ages 18 years and up

    This is a multi-center, prospective, randomized trial of standard of care vs. standard of care + pegfilgrastim (Neulasta®) among patients with a clinical diagnosis of alcoholic hepatitis and DF≥32.

    at UCLA